A pathway to more effective and efficient synthesis of pharmaceutical drugs and other flow reactor chemical products has been opened by a study in which for the first time the catalytic reactivity inside a microreactor was mapped in high resolution from start-to-finish. The results not only provided a better understanding of the chemistry behind the catalytic reactions, they also revealed opportunities for optimization, which resulted in better catalytic performances. The study was conducted by a team of scientists with the U.S. Department of Energy (DOE)'s Lawrence Berkeley National Laboratory (Berkeley Lab) and the University of California (UC) Berkeley.
↧